Skip to main content

Table 2 Sanger and next generation sequencing results

From: Development and analytical validation of a 25-gene next generation sequencing panel that includes the BRCA1 and BRCA2 genes to assess hereditary cancer risk

 

Sanger sequencing

NGS

Samples

100

100

Amplicons (per sample)

370

1969

Bases analyzed (per sample)

88,631

88,631

Total positive bases

3923

3923

•Single base substitutions

3884

3884

•Small indels

39

39

Total negative bases

8,859,177

8,859,177